HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Changsu Han Selected Research

AMPA 4 glutamate receptor ionotropic

6/2013Investigation of possible epistatic interactions between GRIA2 and GRIA4 variants on clinical outcomes in patients with major depressive disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Changsu Han Research Topics

Disease

44Major Depressive Disorder (Major Depressive Disorders)
04/2022 - 01/2007
32Schizophrenia (Dementia Praecox)
11/2021 - 12/2007
11Alzheimer Disease (Alzheimer's Disease)
05/2022 - 01/2010
11Cognitive Dysfunction
05/2022 - 09/2007
11Bipolar Disorder (Manic Depressive Psychosis)
05/2020 - 08/2007
7Mental Disorders (Mental Disorder)
04/2015 - 01/2008
6Dementia (Dementias)
05/2022 - 09/2007
6Delirium
01/2020 - 04/2005
5Weight Gain
08/2013 - 01/2008
4Sleep Initiation and Maintenance Disorders (Insomnia)
05/2019 - 03/2011
4Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
11/2017 - 11/2008
4Mood Disorders (Mood Disorder)
01/2017 - 02/2008
4Anxiety Disorders (Anxiety Disorder)
05/2016 - 01/2008
3Treatment-Resistant Depressive Disorder
01/2020 - 05/2008
3Medically Unexplained Symptoms
09/2015 - 02/2008
3Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2014 - 02/2010
3Fibromyalgia (Fibrositis)
11/2009 - 01/2009
3Tardive Dyskinesia
12/2008 - 01/2008
3Somatoform Disorders (Somatoform Disorder)
06/2008 - 01/2008
2Obesity
01/2021 - 04/2012
2Inflammation (Inflammations)
01/2021 - 04/2019
2Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2017 - 06/2008
2Hallucinations (Hallucination)
08/2015 - 05/2008
2Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
05/2013 - 01/2008
2Fatigue
11/2009 - 10/2007
2Restless Legs Syndrome (Restless Legs)
01/2008 - 12/2007
1Neurobehavioral Manifestations
11/2021
1Amyloid Plaque
01/2020
1Hyponatremia
05/2018
1Hemorrhage
05/2018
1Wounds and Injuries (Trauma)
11/2017
1Body Weight (Weight, Body)
08/2017
1Overweight
08/2017
1Nausea
08/2017
1Psychomotor Agitation (Akathisia)
02/2017
1AIDS-Related Complex (ARC)
01/2017
1Syndrome (Syndromes)
01/2017

Drug/Important Bio-Agent (IBA)

36Antipsychotic Agents (Antipsychotics)IBA
11/2021 - 04/2005
33Antidepressive Agents (Antidepressants)IBA
11/2020 - 10/2007
15Aripiprazole (Abilify)FDA Link
05/2021 - 11/2011
6Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
05/2018 - 01/2008
5Risperidone (Risperdal Consta)FDA LinkGeneric
01/2020 - 04/2005
5Paliperidone PalmitateFDA Link
01/2017 - 03/2011
4Amyloid (Amyloid Fibrils)IBA
12/2021 - 12/2019
4Proteins (Proteins, Gene)FDA Link
05/2020 - 01/2010
4Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2017 - 01/2007
4Vilazodone HydrochlorideIBA
05/2016 - 07/2013
4Paroxetine (Paxil)FDA LinkGeneric
01/2009 - 01/2008
3VortioxetineIBA
04/2022 - 05/2015
3Cholinesterase Inhibitors (Anticholinesterases)IBA
03/2021 - 11/2008
3Biomarkers (Surrogate Marker)IBA
01/2021 - 02/2010
3Pharmaceutical PreparationsIBA
01/2020 - 01/2008
3Dopamine (Intropin)FDA LinkGeneric
06/2017 - 01/2008
3Valproic Acid (Depakote)FDA LinkGeneric
05/2012 - 02/2008
2EscitalopramFDA Link
04/2022 - 01/2008
2Desvenlafaxine SuccinateFDA Link
04/2022 - 01/2009
2Hypnotics and Sedatives (Sedatives)IBA
05/2019 - 03/2011
2Neurotransmitter Agents (Neurotransmitter)IBA
01/2017 - 01/2015
2Amisulpride (Solian)IBA
06/2014 - 07/2012
2Fluoxetine (Prozac)FDA LinkGeneric
06/2014 - 02/2008
2Adenosine Monophosphate (AMP)IBA
04/2014 - 06/2012
2Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
01/2014 - 12/2010
2CholesterolIBA
01/2014 - 02/2010
2Norepinephrine (Noradrenaline)FDA LinkGeneric
07/2013 - 01/2009
2Serotonin (5 Hydroxytryptamine)IBA
07/2013 - 01/2009
2D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA
06/2013 - 11/2011
2Olanzapine (Zyprexa)FDA Link
07/2012 - 01/2008
2Lamotrigine (Lamictal)FDA LinkGeneric
01/2011 - 02/2008
2HomocysteineIBA
12/2010 - 09/2007
2Methylphenidate (Ritalin)FDA LinkGeneric
03/2009 - 06/2008
2Bupropion (Wellbutrin)FDA LinkGeneric
06/2008 - 10/2007
1Tissue Inhibitor of Metalloproteinase-3IBA
05/2022
1Memantine (Namenda)FDA Link
03/2021
1C-Reactive ProteinIBA
01/2021
1Amyloid beta-PeptidesIBA
03/2020
1DexmedetomidineFDA Link
01/2020
1Cadherins (E-Cadherin)IBA
01/2020
1ramelteon (Rozerem)FDA Link
01/2020
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2020
1Zolpidem (Ambien)FDA LinkGeneric
05/2019
1CytokinesIBA
04/2019
1Transcription Factors (Transcription Factor)IBA
10/2018
1Serotonin and Noradrenaline Reuptake InhibitorsIBA
05/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2017
1Donepezil (Aricept)FDA LinkGeneric
08/2017
1Investigational DrugsIBA
06/2017
1Dopamine AntagonistsIBA
06/2017
1brexpiprazoleIBA
02/2017
1Nerve Growth Factors (Neurotrophins)IBA
01/2017
1Modafinil (Provigil)FDA Link
01/2017
1sigma Receptors (sigma Receptor)IBA
01/2017
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2017
1Sigma-1 ReceptorIBA
01/2017

Therapy/Procedure

10Therapeutics
11/2021 - 08/2007
7Injections
08/2021 - 08/2007
4Polypharmacy
11/2021 - 02/2020
2Drug Therapy (Chemotherapy)
01/2020 - 11/2018
2Patient Readmission
10/2015 - 01/2014
2Critical Care (Surgical Intensive Care)
09/2008 - 06/2008
1Aftercare (After-Treatment)
11/2017